Probiotics and colon cancer

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 17, Issue 5, 2003, Pages 849-859

  Rafter, Joseph ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Chemoprevention; Colon cancer; Intestinal microflora; Probiotics

Indexed keywords

1,2 DIMETHYLHYDRAZINE; 2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; 3 METHYLCHOLANTHRENE; AZOXYMETHANE; BETA GLUCURONIDASE; CARCINOGEN; CYTOCHROME P450; DIPEPTIDYL PEPTIDASE IV; DNA; GAMMA INTERFERON; GLUCURONIDE; GLUTATHIONE TRANSFERASE; INTERLEUKIN 6; NITROSOGUANIDINE; ORNITHINE DECARBOXYLASE; PLACEBO; PROBIOTIC AGENT; PROTEIN P21; RAS PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TUMOR NECROSIS FACTOR ALPHA; YOGHURT;

ANTINEOPLASTIC ACTIVITY; BACTERIUM CULTURE; CANCER INHIBITION; CLINICAL TRIAL; COLON CANCER; DAIRY PRODUCT; DIET THERAPY; DRUG MECHANISM; EXPERIMENTAL MODEL; FERMENTATION; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; INTESTINE FLORA; LABORATORY TEST; LACTIC ACID BACTERIUM; MEDICAL LITERATURE; NONHUMAN; REVIEW; BIFIDOBACTERIUM; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SURVIVAL; COLON CARCINOGENESIS; COLORECTAL CANCER; DIET SUPPLEMENTATION; DRUG INHIBITION; INTESTINE MUCOSA; LACTOBACILLUS; MILK; MUTAGENIC ACTIVITY;

ANIMALS; COLONIC NEOPLASMS; HUMANS; INTESTINES; LACTOBACILLUS; PROBIOTICS;

EID: 0347983830     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6918(03)00056-8     Document Type: Review

References (73)

1. Salminen S. Bouley C. Boutron-Ruault M.-C. et al. Functional food science and gastrointestinal physiology and function British Journal of Nutrition 80 supplement 1998 s147-s171
2. Pool-Zobel B.L. Neudecker C. Domizlaff I. et al. Lactobacillus- and Bifidobacterium-mediated antigenotoxicity in the colon of rats Nutrition in Cancer 26 1996 365-380
3. Goldin B.R. Gualtieri L.J. Moore R.P. The effect of Lactobacillus GG on the initiation and promotion of DMH-induced intestinal tumors in the rat Nutrition in Cancer 25 1996 197-204
4. Arimochi H. Kinouchi T. Kataoka K. et al. Effect of intestinal bacteria on formation of azoxymethane-induced aberrant crypt foci in the rat colon Biochemical and Biophysical Research Communications 238 1997 753-757
5. Challa A. Rao D.R. Chawan C.B. Shackelford L. Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats Carcinogenesis 18 1997 517-521
6. Kulkarni N. Reddy B.S. Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial β-glucuronidase Proceedings of the Society for Experimental Biology in Medicine 207 1994 278-283
7. Abdelali H. Cassand P. Soussotte V. et al. Effect of dairy products on initiation of precursor lesions of colon cancer in rats Nutrition in Cancer 24 1995 121-132
8. Gallaher D.D. Stallings W.H. Blessing L.L. et al. Probiotics, cecal microflora, and aberrant crypts in the rat colon Journal of Nutrition 126 1996 1362-1371
9. Rowland I.R. Rumney C.J. Coutts J.T. Lievense L.C. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats Carcinogenesis 19 1998 281-285
10. Onoue M. Kado S. Sakaitani Y. et al. Specific species of intestinal bacteria influence the induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats Cancer Letters 113 1997 179-186
11. Reddy B.S. Rivenson A. Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen Cancer Research 53 1993 3914-3918
12. Kohwi T. Imai K. Tamura A. Hashimoto Y. Antitumor effect of Bifidobacterium infantis in mice Gann 69 1978 613-618
13. Goldin B.R. Gorbach S.L. Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats Journal of the National Cancer Institute 64 1980 263-265
14. Shackelford L.A. Rao D.R. Chawan C.B. Pulusani S.R. Effect of feeding fermented milk on the incidence of chemically-induced colon tumors in rats Nutrition in Cancer 5 1983 159-164
15. Singh J. Rivenson A. Tomita M. et al. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis Carcinogenesis 18 1997 833-841
16. Friend B.A. Farmer R.E. Shahani K.M. Effect of feeding and intraperitoneal implantation of yogurt culture cells on Ehrlich ascites tumor Milch Wissenschaft 37 1982 708-710
17. Kato I. Kobayashi S. Yokokura T. Mutai M. Antitumor activity of Lactobacillus casei in mice Gann 72 1981 517-523
18. Sekine K. Toida T. Saito M. et al. A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice Cancer Research 45 1985 1300-1307
19. Hirayama K. Itoh K. Takahashi E. Mitsuoka T. Comparison of composition of faecal microbiota and metabolism of faecal bacteria among 'human-flora-associated' mice inoculated with faeces from six different human donors Microbial Ecolology in Health and Disease 8 1995 199-211
20. Horie H. Zeisig M. Hirayama K. et al. Probiotic mixture decreases DNA adduct formation in colonic epithelium induced by the food mutagen 2-amino-9H-pyrido(2,3-b)indole in a human-flora associated mouse model European Journal of Cancer Prevention 12 2003 101-107
21. Hirayama K. Baranczewski P. Åkerland J.-E. et al. Effects of human intestinal flora on mutagenicity of and DNA adduct formation from food and environmental mutagens Carcinogenesis 21 2000 2105-2111
22. Seo G. Shimizu K. Sasatsu M. Kono M. Inhibition of growth of some enteropathogenic strains in mixed cultures of Streptococcus faecalis and Clostridium butyricum Microbios Letters 40 1989 151-160
23. Iino H. Fukaya K. Hirasawa Y. et al. Stimulation of bacterial growth of some strains of Bifidobacterium by a crude preparation of metabolites from Bacillus mesentericus TO-A Biomedical Letters 48 1993 73-78
24. Seo G. Akimoto Y. Hamashima H. et al. A new factor from Bacillus mesentericus which promotes the growth of Bifidobacterium Microbios 101 2000 105-114
25. Lidbeck A. Overvik E. Rafter J. et al. Effect of Lactobacillus acidophilus supplements on mutagen excretion in feces and urine in humans Microbial Ecology in Health and Disease 5 1992 59-67
26. Hayatsu H. Hayatsu T. Suppressing effect of Lactobacillus casei administration on the urinary mutagenicity arising from ingestion of fried ground beef in the human Cancer Letters 73 1993 173-179
27. Shahani K.M. Ayebo A.D. Role of dietary lactobacilli in gastrointestinal microecology American Journal of Clinical Nutrition 33 1980 2448-2457
28. Malhotra S.L. Dietary factors in a study of colon cancer from cancer registry, with special reference to the role of saliva, milk, and fermented milk products and vegetable fibre Medical Hypotheses 3 1977 122-134
29. Intestinal Microecology Group, International Agency for Research on Cancer Dietary fibre, transit time, fecal bacteria, steroids, and colon cancer in two Scandinavian populations Lancet 2 1977 207-211
30. Peters R.K. Pike M.C. Garabrant D. Mack T.M. Diet and colon cancer in Los Angeles County, California Cancer Causes and Control 3 1992 457-473
31. Young T.B. Wolf D.A. Case-control study of proximal and distal colon cancer and diet in Wisconsin International Journal of Cancer 42 1988 167-175
32. Boutron M.C. Faivre J. Marteau P. et al. Calcium, phosphorous, vitamin D, dairy products and colorectal carcinogenesis: a French case-control study British Journal of Cancer 74 1996 145-151
33. van't Veer P. Dekker J.M. Lamers J.W.J. et al. Consumption of fermented milk products and breast cancer: a case-control study in the Netherlands Cancer Research 49 1989 4020-4023
34. Le M.G. Moulton L.H. Hill C. Kramer A. Consumption of dairy produce and alcohol in a case-control study of breast cancer Journal of the National Cancer Institute 77 1986 633-636
35. Kampman E. Giovannucci E. van't Veer P. et al. Calcium, vitamin D, dairy foods, and the occurrence of colorectal adenomas among men and women in two prospective studies American Journal of Epidemiology 139 1994 16-29
36. Kampman E. Goldbohm R.A. van den Brandt P.A. van't Veer P. Fermented dairy products, calcium, and colorectal cancer in the Netherlands cohort study Cancer Research 54 1994 3186-3190
37. Kulkarni N. Reddy B.S. Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial β-glucuronidase Proceedings of the Society of Experimental Biology and Medicine 207 1994 278-283
38. Abdelali H. Cassand P. Soussotte V. et al. Effect of dairy products on initiation of precursor lesions of colon cancer in rats Nutrition in Cancer 24 1995 121-132
39. Rowland I.R. Rumney C.J. Coutts J.T. Lievense L.C. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats Carcinogenesis 19 1998 281-285
40. Goldin B.R. Gorbach S.L. Alterations of the intestinal microflora by diet, oral antibiotics and Lactobacillus: decreased production of free amines from aromatic nitro compounds, azo dyes and glucuronides Journal of the National Cancer Institute 73 1984 689-695
41. Ayebo A.D. Angelo I.A. Shahani K.M. Effect of ingesting Lactobacillus acidophilus milk upon fecal flora and enzyme activity in humans Milch Wissenschaft 35 1980 730-733
42. Ling W.H. Korpela R. Mykkanen H. et al. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults Journal of Nutrition 124 1994 18-23
43. Goldin B.R. Swenson L. Dwyer J. et al. Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes Journal of the National Cancer 64 1980 255-261
44. Spanhaak S. Havenaar R. Schaafsma G. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans European Journal of Clinical Nutrition 52 1998 899-907
45. Goldin B.R. Gorbach S.L. The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity American Journal of Clinical Nutrition 39 1984 756-761
46. Modler G.W. McKellar R.C. Yaguchi M. Bifidobacteria and bifidogenic factors Canadian Institute of Food Science and Technology Journal 23 1990 29-41
47. Bartram H.P. Scheppach W. Gerlach S. et al. Does yogurt enriched with Bifidobacterium longum affect colonic microbiology and fecal metabolites in healthy subjects American Journal of Clinical Nutrition 59 1994 428-432
48. Weisburger J.H. Wynder E.L. Etiology of colorectal cancer with emphasis on mechanism of action and prevention. In De Vita V.T. Hellman S. & Rosenberg S.A. (Eds.), Important Advances in Oncology 1987 197-220 JB Lippincott Philadelphia
49. Bruce W.R. Recent hypotheses for the origin of colon cancer Cancer Research 47 1987 4237-4242
50. Lidbeck A. Geltner-Allinger U. Orrhage K.M. et al. Impact of Lactobacillus acidophilus supplements on the faecal microflora and soluble faecal bile acids in colon cancer patients Microbial Ecology in Health and Disease 4 1991 81-88
51. Biasco G. Paganelli G.M. Brandi G. et al. Effect of Lactobacillus acidophilus and Bifidobacterium bifidum on rectal cell kinetics and fecal pH Italian Journal of Gastroenterology 23 1991 142
52. Orrhage K. Sillerstrom E. Gustafsson J.-A. et al. Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria Mutation Research 311 1994 239-248
53. Morotomi M. Mutai M. In vitro binding of potent mutagenic pyrolysates to intestinal bacteria Journal of National Cancer Institute 77 1986 195-201
54. Zhang X.B. Ohta Y. Microorganisms in the gastrointestinal tract of the rat prevent absorption of the mutagen-carcinogen 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole Canadian Journal of Microbiology 39 1993 841-845
55. Orrhage K. Annas A. Nord C.E. et al. Effects of lactic acid bacteria on the uptake and distribution of the food mutagen Trp-P-2 in mice Scandinavian Journal of Gastroenterology 37 2002 215-221
56. Rowland I.R. Grasso P. Degradation of N-nitrosamines by intestinal bacteria Applied Microbiology 29 1975 7-12
57. Shahani K.M. Ayebo A.D. Role of dietary lactobacilli in gastrointestinal microecology American Journal of Clinical Nutrition 33 1980 2448-2457
58. Reddy G.V. Friend B.A. Shahani K.M. Farmer R.E. Antitumor activity of yogurt components Journal of Food Protection 46 1983 8-11
59. Reddy G.V. Shahani K.M. Benerjee M.R. Inhibitory effect of yogurt on Ehrlich ascites tumor cell proliferation Journal of the National Cancer Institute 50 1973 815-817
60. Baricault L. Denariaz G. Houri J.-J. et al. Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation Carcinogenesis 16 1995 245-252
61. Biffi A. Coradini D. Larsen R. et al. Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line Nutrition in Cancer 28 1997 93-99
62. Sekine K. Toida T. Saito M. et al. A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice Cancer Research 45 1985 1300-1307
63. Schiffrin E.J. Rochat F. Link-Amster H. et al. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria Journal of Dairy Science 78 1995 491-496
64. De Simone C. Vesely R. Bianchi Salvadori B. Jirillo E. The role of probiotics in modulation of the immune system in man and in animals International Journal of Immunotherapy 9 1993 23-28
65. Kato I. Yokokura T. Mutai M. Macrophage activation by Lactobacillus casei in mice Microbiology and Immunology 27 1983 611-618
66. Matsuzaki T. Immunomodulation by treatment with Lactobacillus casei strain Shirota International Journal of Food Microbiology 41 1998 133-140
67. Kato I. Endo K. Yokokura T. Effects of oral adminstration of Lactobacillus casei on antitumor responses induced by tumor resection in mice International Journal of Immunopharmacology 16 1994 29-36
68. Sekine K. Kawashima T. Hashimoto Y. Comparison of the TNF-α levels induced by human-derived Bifidobacterium longum and rat-derived Bifidobacterium animalis in mouse peritoneal cells Bifidobacteria Microflora 13 1994 79-89
69. Venitt S. Mutagens in human faeces and cancer of the large bowel. In Rowland I.R. (Ed.), Role of the Gut Flora in Toxicity and Cancer 1988 399-460 Academic Press London
70. Fang W.-F. Strobel H.W. Activation of carcinogens and mutagens by rat colon mucosa Cancer Research 38 1978 2939-2944
71. Pool-Zobel B.L. Neudecker C. Domizlaff I. et al. Lactobacillus- and Bifidobacterium-mediated antigenotoxicity in the colon of rats Nutrition in Cancer 26 1996 365-380
72. Challa A. Rao D.R. Chawan C.B. Shackelford L. Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats Carcinogenesis 18 1997 517-521
73. Reddy B.S. Prevention of colon cancer by pre- and probiotics: evidence from laboratory studies British Journal of Nutrition 80 1998 S219-S223